These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 6132964)
1. Neuroleptic binding sites: specific labeling in mice with [18F]haloperidol, a potential tracer for positron emission tomography. Zanzonico PB; Bigler RE; Schmall B J Nucl Med; 1983 May; 24(5):408-16. PubMed ID: 6132964 [TBL] [Abstract][Full Text] [Related]
2. Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers. Logan J; Wolf AP; Shiue CY; Fowler JS J Neurochem; 1987 Jan; 48(1):73-83. PubMed ID: 2432176 [TBL] [Abstract][Full Text] [Related]
3. Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography. Arnett CD; Shiue CY; Wolf AP; Fowler JS; Logan J; Watanabe M J Neurochem; 1985 Mar; 44(3):835-44. PubMed ID: 2579198 [TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol. Karbe H; Wienhard K; Hamacher K; Huber M; Herholz K; Coenen HH; Stöcklin G; Lövenich A; Heiss WD J Neural Transm Gen Sect; 1991; 86(3):163-73. PubMed ID: 1837996 [TBL] [Abstract][Full Text] [Related]
5. Regional distribution and kinetics of haloperidol binding in human brain: a PET study with [18F]haloperidol. Schlyer DJ; Volkow ND; Fowler JS; Wolf AP; Shiue CY; Dewey SL; Bendriem B; Logan J; Raulli R; Hitzemann R Synapse; 1992 May; 11(1):10-9. PubMed ID: 1604422 [TBL] [Abstract][Full Text] [Related]
6. Dopaminergic receptor sites in human brain: positron emission tomography. Baron JC; Comar D; Zarifian E; Agid Y; Crouzel C; Loo H; Deniker P; Kellershohn C Neurology; 1985 Jan; 35(1):16-24. PubMed ID: 3871249 [TBL] [Abstract][Full Text] [Related]
7. Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor. Welch MJ; Kilbourn MR; Mathias CJ; Mintun MA; Raichle ME Life Sci; 1983 Oct; 33(17):1687-93. PubMed ID: 6633162 [TBL] [Abstract][Full Text] [Related]
8. Haloperidol blocks the uptake of [18F]N-methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patients. Yousef KA; Volkow ND; Schlyer DJ; Fowler JS; Wolf AP; Wang GJ; Smith MR; Brodie JD; Warner D Synapse; 1995 Jan; 19(1):14-7. PubMed ID: 7709339 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of specific in vivo labeling of neuroleptic binding sites with 3-N-[11C]methylspiperone. Yanai K; Ido T; Ishiwata K; Hatazawa J; Watanuki S; Takahashi T; Ujiie A; Ito M; Matsuzawa T Eur J Nucl Med; 1986; 11(11):438-43. PubMed ID: 3486764 [TBL] [Abstract][Full Text] [Related]